3 more GREAT ASX growth stocks

I own all three of these stocks and suggest you do too.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Earlier today I offered up three great ASX small cap stocks for all serious investors to consider. Here are another three with good dividends and better growth prospects than most stocks in S&P/ASX 200 (ASX: XJO) (INDEX: ^AXJO).

4. ADMEDUS FPO (ASX: AHZ) is a junior diversified biotechnology company with significant growth potential, even from its current price around 14 cents per share. This morning the company released an update on its activities and said revenues for FY14 are expected to be over $9 million (FY13: $7.4 million). With its flagship CardioCel regenerative technology now selling worldwide, increased cash flows and profits are expected. Since I made it my top stock pick in October 2013, it's up around 60%, but I'm not the only one who thinks it's got plenty of room left to run. Both Ballieu Holst and Morgans CIMB have price targets on the stock of 25 cents and 23 cents, respectively.

5. Bentham IMF Ltd (ASX: IMF) is a litigation funder for claims of at least $5 million. It has an impeccable track record with picking successful cases and has been rewarded by investors accordingly. Given the nature of its business (earnings can be "lumpy" depending on when cases are settled), investors considering buying in must be long-term focused and should not try and extrapolate near-term forecasts. For example since 2001, IMF's share price has climbed over 871% but in four of those years its share price depreciated. With more claims under its belt and a wider global network, investors can remain confident in its bright future.

6. Shine Corporate Ltd (ASX: SHJ) is an Australian law firm with an expanding footprint outside its native Queensland. Shine is looking to expand its Personal Injury offering and also grow into "emerging practice areas" which are under-served by other national law firms. As a result its branch network is rapidly expanding both organically and acquisitively. It recently announced the acquisition of Stephen Browne Personal Injury Lawyers, a plaintiff litigation firm based in Western Australia and Emanate Legal, a firm with specialist knowledge of landowner access rights, based in Queensland. It pays a modest but growing 1.2% dividend.

Get our BEST small-cap dividend stock for FREE!

Motley Fool Contributor Owen Raszkiewicz owns shares in Shine Corporate Ltd, Bentham IMF Ltd and Admedus.  

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »